Valuation: Boston Scientific Corporation

Market Cap 71.46B 61.81B 57.73B 52.95B 99.6B 6,801B 101B 677B 266B 3,409B 268B 262B 11,270B P/E 2026 *
18.4x
P/E 2027 * 19.2x
Enterprise Value 80.18B 69.35B 64.77B 59.41B 112B 7,631B 114B 760B 298B 3,825B 301B 294B 12,644B EV / Sales 2026 *
3.75x
EV / Sales 2027 * 3.44x
Free-Float
82.49%
Yield 2026 *
-
Yield 2027 * -
1 day+0.02%
1 week+5.52%
Current month+5.52%
1 month+10.04%
3 months-8.57%
6 months-35.35%
Current year-48.29%
1 week 47.1
Extreme 47.1
50.16
1 month 42.2
Extreme 42.2
50.16
Current year 42.2
Extreme 42.2
100.9
1 year 42.2
Extreme 42.2
109.5
3 years 42.2
Extreme 42.2
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 01/11/2011
Director of Finance/CFO 52 30/06/2025
Chief Tech/Sci/R&D Officer - 01/09/2009
Director TitleAgeSince
Chairman 61 03/05/2016
Director/Board Member 74 01/03/2014
Director/Board Member 74 15/04/2016
Date Insider Type Main position Quantity % Market Cap.
04/08/26 Buy

Director

140 0.0000%
03/08/26 Buy

Chief Executive Officer

208,359 0.0141%
31/07/26 Other

Executive/Senior Manager

64,198 0.0043%
Change 5-day change 1-year change 3-year change Capi.($)
+0.02%+5.52%-52.19%-2.51% 71.46B
+2.41%+3.43%+28.93%+6.88% 220B
+2.39%+5.02%+2.09%-20.96% 144B
+1.36%+7.21%-19.42%+25.07% 134B
+0.45%+4.24%+14.51%+14.16% 51.71B
+1.05%+7.19%-14.90%-17.93% 50.84B
+3.28%+5.49%+27.35%+13.73% 41.23B
+1.79%+7.83%+44.69%+37.11% 39.95B
+2.08%+5.51%-0.32%-2.92% 32.42B
-5.06%+0.46%-25.35%+18.22% 30.57B
Average +0.98%+5.04%+0.54%+7.09% 81.56B
Weighted average by Cap. +1.54%+5.00%+3.00%+4.91%

Financials

2026 *2027 *
Net sales 21.37B 18.48B 17.26B 15.83B 29.78B 2,033B 30.25B 202B 79.48B 1,019B 80.23B 78.48B 3,369B 22.34B 19.32B 18.04B 16.55B 31.13B 2,126B 31.63B 212B 83.09B 1,066B 83.88B 82.04B 3,523B
Net income 3.84B 3.32B 3.1B 2.85B 5.36B 366B 5.44B 36.42B 14.3B 183B 14.43B 14.12B 606B 3.74B 3.23B 3.02B 2.77B 5.21B 356B 5.29B 35.43B 13.91B 178B 14.04B 13.73B 590B
Net Debt 8.72B 7.54B 7.04B 6.46B 12.15B 830B 12.34B 82.61B 32.43B 416B 32.73B 32.02B 1,375B 5.45B 4.72B 4.4B 4.04B 7.6B 519B 7.72B 51.67B 20.28B 260B 20.47B 20.02B 860B
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
07/08/26 $49.31 +0.02% 11,447,002
06/08/26 $49.30 +3.27% 21,398,972
05/08/26 $47.74 -2.75% 16,512,147
04/08/26 $49.09 +1.36% 21,565,121
03/08/26 $48.43 +3.64% 20,379,998
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
49.31USD
Average target price
62.69USD
Spread / Average Target
+27.13%

Quarterly revenue - Rate of surprise